Vitrolife
Stock
Stock
ISIN: SE0011205202
Ticker: VITR
SE0011205202
VITR
Price
Price
CHART BY
Historical dividends and forecast
Vitrolife has so far distributed $0.118 in 2026. The next dividend will be paid on 12.05.2027
$0.062
CHART BY
Frequently asked questions
What is Vitrolife's market capitalization?
The market capitalization of Vitrolife is $1.28B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Vitrolife?
Vitrolife's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.743. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Vitrolife's stock?
Currently, 5 analysts cover Vitrolife's stock, with a consensus target price of $12.08. Analyst ratings provide insights into the stock's expected performance.
What is Vitrolife's revenue over the trailing twelve months?
Over the trailing twelve months, Vitrolife reported a revenue of $344.88M.
What is the EBITDA for Vitrolife?
Vitrolife's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $107.74M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Vitrolife?
Vitrolife has a free cash flow of $62.36M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Vitrolife have, and what sector and industry does it belong to?
Vitrolife employs approximately 1,151 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Vitrolife's shares?
The free float of Vitrolife is 70.39M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.28B
- EPS (TTM)
- -$3.743
- Free Float
- 70.39M
- Revenue (TTM)
- $344.88M
- EBITDA (TTM)
- $107.74M
- Free Cashflow (TTM)
- $62.36M
Pricing
- 1D span
- $9.131$9.461
- 52W span
- $8.662$16.33
Analyst Ratings
The price target is $12.08 and the stock is covered by 5 analysts.
Buy
3
Hold
2
Sell
0
Information
Vitrolife AB develops, produces, and markets products for creating, prolonging, and improving life. It focuses on fertility treatments, cell therapy and tissue engineering, and organ transplantation systems. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
- Employees
- 1,151
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0011205202
- Primary Ticker
- VITR
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet